Pacific Biosciences of California, Inc. Deferred Tax Liabilities, Tax Deferred Income
Pacific Biosciences of California, Inc. (PACB) had Deferred Tax Liabilities, Tax Deferred Income of $786.00 thousand as of 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome · last filed 2021-02-26
- 2020-12-31: Deferred Tax Liabilities, Tax Deferred Income $786.00K.
- 2019-12-31: Deferred Tax Liabilities, Tax Deferred Income $1.43M.
- 2018-12-31: Deferred Tax Liabilities, Tax Deferred Income $2.19M.
- 2017-12-31: Deferred Tax Liabilities, Tax Deferred Income $2.22M.
| Period end | Deferred Tax Liabilities, Tax Deferred Income |
|---|---|
| 2020-12-31 | $786.00K 10-K · filed 2021-02-26 |
| 2019-12-31 | $1.43M 10-K · filed 2021-02-26 |
| 2018-12-31 | $2.19M 10-K · filed 2020-02-28 |
| 2017-12-31 | $2.22M 10-K · filed 2019-02-26 |
| 2016-12-31 | $72.00K 10-K · filed 2018-02-26 |
| 2015-12-31 | $237.00K 10-K · filed 2017-03-06 |
| 2014-12-31 | $1.41M 10-K · filed 2016-03-11 |
| 2013-12-31 | $846.00K 10-K · filed 2015-03-12 |
| 2012-12-31 | $430.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | $27.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |